Professor of Urology University of california Los Angeles, United States
Learning Objectives :
At the end of this session, attendees should be able to:
Recall the fundamentals of PSMA imaging and radioligand therapy in the contemporary management of prostate cancer.
Summarize the basics of PSMA PET/CT imaging acquisition, interpretation, and clinical indications as well as its role in guiding treatment decision-making in the prostate cancer management.
Outline the current PSMA-targeted radioligand therapies and supporting clinical evidence in the management of patients with mCRPC.
Recognize the role of a multidisciplinary tumour board in guiding the management of patients with advanced prostate cancer in clinical practice.
